Neuroimmune alterations in the complex regional pain syndrome
- 1 October 2001
- journal article
- review article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 429 (1-3) , 101-113
- https://doi.org/10.1016/s0014-2999(01)01310-3
Abstract
No abstract availableKeywords
This publication has 130 references indexed in Scilit:
- Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid ArthritisJAMA, 2000
- Treatment with anti-tumor necrosis factor α (TNF-α) monoclonal antibody dramatically decreases the clinical activity of psoriasis lesionsJournal of the American Academy of Dermatology, 2000
- Cyclo‐oxygenase‐2: pharmacology, physiology, biochemistry and relevance to NSAID therapyBritish Journal of Pharmacology, 1999
- Corticosteroid resistance in mild asthma: markers of persistent inflammationAnnals of Allergy, Asthma & Immunology, 1999
- Infliximab for the Treatment of Fistulas in Patients with Crohn's DiseaseNew England Journal of Medicine, 1999
- External validation of IASP diagnostic criteria for Complex Regional Pain Syndrome and proposed research diagnostic criteriaPain, 1999
- Case reports and hypothesis: A neglect-like syndrome may be responsible for the motor disturbance in reflex sympathetic dystrophy (complex regional pain syndrome-1)Journal of Pain and Symptom Management, 1995
- Plasma neuropeptide Y in the symptomatic limb of patients with causalgic painClinical Autonomic Research, 1994
- Small reduction of capsaicin-induced neurogenic inflammation in human forearm skin by the glucocorticoid prednicarbateInflammation Research, 1993
- Actions of prostaglandin E2 metabolites on skin microcirculationInflammation Research, 1985